Cynvec

Cynvec is an early-stage biotechnology company located in New York City. It was founded in 2004 through the exclusive licensing of IP transferred from New York University and focuses on the application of the Sindbis oncolytic virus vector in cancer treatment. The company is based on the work of world-leading virus expert and New York University professor, Dr. Daniel Meruelo. Cynvec is preparing an Investigational New Drug (IND) application for our first product, CYN 101.